サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：幹細胞治療の世界市場：細胞源別（脂肪組織由来MSC、骨髄由来MSC、胎盤/臍帯由来MSC、その他）、種類別、治療用途別、地域別の市場規模調査と予測（2022年～2028年）
市場調査レポート
商品コード
1070328

幹細胞治療の世界市場：細胞源別（脂肪組織由来MSC、骨髄由来MSC、胎盤/臍帯由来MSC、その他）、種類別、治療用途別、地域別の市場規模調査と予測（2022年～2028年）

Global Stem Cell Therapy Market Size study, By Cell Source (Adipose tissue-derived MSCs, Bone marrow-derived MSCs, Placental/umbilical cord-derived MSCs, Other Cell Sources), By Type, By Therapeutic Application, and Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
幹細胞治療の世界市場：細胞源別（脂肪組織由来MSC、骨髄由来MSC、胎盤/臍帯由来MSC、その他）、種類別、治療用途別、地域別の市場規模調査と予測（2022年～2028年）
出版日: 2022年03月27日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の幹細胞治療の市場規模は、2021年に約1億6,052万米ドルとなり、2022年から2028年の予測期間中に16.5％以上の健全な成長率で拡大すると予測されています。

当レポートでは、世界の幹細胞治療市場を調査し、市場の概要、市場分析、細胞源別・種類別・治療用途別・地域別の分析、および競合情勢など、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の幹細胞治療市場の定義と範囲

第3章 世界の幹細胞治療市場力学

  • 幹細胞治療市場の影響分析（2020年～2028年）

第4章 世界の幹細胞治療市場の業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要な投資機会
  • 主要な成功戦略

第5章 リスク評価：COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19以前およびCOVID-19後の市場シナリオ

第6章 世界の幹細胞治療市場：細胞源別

  • 市場スナップショット
  • 実績 - 潜在的な分析：細胞源別
  • 市場規模の推計と予測：細胞源別、2019年～2028年（100万米ドル）
  • サブセグメント分析
    • 脂肪組織由来MSC（間葉系幹細胞）
    • 骨髄由来MSC
    • 胎盤/臍帯由来MSC
    • その他

第7章 世界の幹細胞治療市場：種類別

  • 市場スナップショット
  • 実績 - 潜在的な分析：種類別
  • 市場規模の推計と予測：種類別、2019年～2028年（100万米ドル）
  • サブセグメント分析
    • 同種幹細胞治療
    • 自家幹細胞治療

第8章 世界の幹細胞治療市場：治療用途別

  • 市場スナップショット
  • 実績 - 潜在的な分析：治療用途別
  • 市場規模の推計と予測：治療用途別、2019年～2028年（100万米ドル）
  • サブセグメント分析
    • 筋骨格系疾患
    • 創傷・外傷
    • 心血管疾患
    • 手術
    • 炎症性疾患・自己免疫疾患
    • 神経系疾患
    • その他

第9章 世界の幹細胞治療市場、地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • その他の地域

第10章 競合情報

  • 主要な市場戦略
  • 企業プロファイル
    • MEDIPOST
    • Anterogen
    • Regrow Biosciences
    • Stempeutics Research
    • CORESTEM
    • PHARMICELL
    • NuVasive
    • RTI Surgical
    • AlloSource
    • JCR Pharmaceuticals

第11章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Stem Cell Therapy Market, report scope
  • TABLE 2. Global Stem Cell Therapy Market estimates & forecasts by Region 2019-2028 (USD Million)
  • TABLE 3. Global Stem Cell Therapy Market estimates & forecasts by Cell Source 2019-2028 (USD Million)
  • TABLE 4. Global Stem Cell Therapy Market estimates & forecasts by Type 2019-2028 (USD Million)
  • TABLE 5. Global Stem Cell Therapy Market estimates & forecasts by Therapeutic Application 2019-2028 (USD Million)
  • TABLE 6. Global Stem Cell Therapy Market by segment, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 7. Global Stem Cell Therapy Market by region, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 8. Global Stem Cell Therapy Market by segment, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 9. Global Stem Cell Therapy Market by region, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 10. Global Stem Cell Therapy Market by segment, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 11. Global Stem Cell Therapy Market by region, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 12. Global Stem Cell Therapy Market by segment, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 13. Global Stem Cell Therapy Market by region, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 14. Global Stem Cell Therapy Market by segment, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 15. Global Stem Cell Therapy Market by region, estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 16. U.S. Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 17. U.S. Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 18. U.S. Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 19. Canada Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 20. Canada Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 21. Canada Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 22. UK Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 23. UK Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 24. UK Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 25. Germany Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 26. Germany Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 27. Germany Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 28. RoE Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 29. RoE Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 30. RoE Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 31. China Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 32. China Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 33. China Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 34. India Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 35. India Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 36. India Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 37. Japan Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 38. Japan Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 39. Japan Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 40. RoAPAC Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 41. RoAPAC Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 42. RoAPAC Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 43. Brazil Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 44. Brazil Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 45. Brazil Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 46. Mexico Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 47. Mexico Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 48. Mexico Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 49. RoLA Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 50. RoLA Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 51. RoLA Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 52. Row Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
  • TABLE 53. Row Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 54. Row Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
  • TABLE 55. List of secondary sources, used in the study of global Stem Cell Therapy Market
  • TABLE 56. List of primary sources, used in the study of global Stem Cell Therapy Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Stem Cell Therapy Market, research methodology
  • FIG 2. Global Stem Cell Therapy Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Stem Cell Therapy Market, key trends 2021
  • FIG 5. Global Stem Cell Therapy Market, growth prospects 2022-2028
  • FIG 6. Global Stem Cell Therapy Market, porters 5 force model
  • FIG 7. Global Stem Cell Therapy Market, pest analysis
  • FIG 8. Global Stem Cell Therapy Market, value chain analysis
  • FIG 9. Global Stem Cell Therapy Market by segment, 2019 & 2028 (USD Million)
  • FIG 10. Global Stem Cell Therapy Market by segment, 2019 & 2028 (USD Million)
  • FIG 11. Global Stem Cell Therapy Market by segment, 2019 & 2028 (USD Million)
  • FIG 12. Global Stem Cell Therapy Market by segment, 2019 & 2028 (USD Million)
  • FIG 13. Global Stem Cell Therapy Market by segment, 2019 & 2028 (USD Million)
  • FIG 14. Global Stem Cell Therapy Market, regional snapshot 2019 & 2028
  • FIG 15. North America Stem Cell Therapy Market 2019 & 2028 (USD Million)
  • FIG 16. Europe Stem Cell Therapy Market 2019 & 2028 (USD Million)
  • FIG 17. Asia pacific Market 2019 & 2028 (USD Million)
  • FIG 18. Latin America Stem Cell Therapy Market 2019 & 2028 (USD Million)
  • FIG 19. Global Stem Cell Therapy Market, company Market share analysis (2021)
目次

Global Stem Cell Therapy Market is valued approximately USD 160.52 million in 2021 and is anticipated to grow with a healthy growth rate of more than 16.5% over the forecast period 2022-2028.

Stem cells are cells with the ability to grow into various different forms of cells in both animal and human bodies. These cells are majorly served as a repair system for the body and are often used in medicine and surgery. Stem cell therapy is also commonly called centerpiece therapy or regenerative medicine. Regenerative medications have the potential to revive cells and replace those that have been damaged or died. This cell therapy is used to treat a variety of chronic conditions, involves blood and cancer disorders. The growing prevalence of chronic disorders, availability of funding for stem cell research, increasing number of approvals for cell therapy production facilities, coupled with the rising clinical trials for stem cell based-therapies are the primary factors that may surge the market demand across the globe. For instance, in September 2020, Stemedica Cell Technologies get investigational new drug (IND) approval by the US FDA for the its intravenous allogeneic mesenchymal stem cells (MSCs) for curing moderate to severe COVID-19 patients. Moreover, increasing initiatives by the public and private organizations to spread awareness and development in medical technology, along with rising government investments in healthcare facilities are further factors, which, in turn, surge the global market demand. However, the high cost of cell-based research and ethical concerns associated with the embryonic stem cells impede the growth of the market over the forecast period of 2022-2028. Also, growing demand for cell & gene therapies and the emergence of induced pluripotent stem cells (iPSCs) as an alternative to Embryonic stem cells (ESCs) are anticipated to act as a catalyzing factor for the market demand during the forecast period.

The key regions considered for the global Stem Cell Therapy Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the increasing number of clinical trials and growing public-private funding and research grants for evolving safe & effective stem cell therapy products. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as increasing government support, growing investment in the healthcare sector, as well an escalating patient pool, would create lucrative growth prospects for the Stem Cell Therapy Market across the Asia-Pacific region.

Major market players included in this report are:

MEDIPOST

Anterogen

Regrow Biosciences

Stempeutics Research

CORESTEM

PHARMICELL

NuVasive

RTI Surgical

AlloSource

JCR Pharmaceuticals

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Cell Source

Adipose Tissue-Derived Mscs (Mesenchymal Stem Cells),

Bone Marrow-Derived Mscs,

Placental/Umbilical Cord-Derived Mscs, And

Other Cell Sources

By Type

Allogeneic Stem Cell Therapy

Autologous Stem Cell Therapy

By Therapeutic Application

Musculoskeletal Disorders

Wounds & Injuries,

Cardiovascular Diseases

Surgeries,

Inflammatory & Autoimmune Diseases

Neurological Disorders,

Other

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Stem Cell Therapy Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Global Stem Cell Therapy Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Global Stem Cell Therapy Market, by Cell Source, 2020-2028 (USD Million)
    • 1.2.3. Global Stem Cell Therapy Market, by Type, 2020-2028 (USD Million)
    • 1.2.4. Global Stem Cell Therapy Market, by Therapeutic Application, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Stem Cell Therapy Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Stem Cell Therapy Market Dynamics

  • 3.1. Stem Cell Therapy Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising number of GMP-certification approvals for cell therapy production facilities
      • 3.1.1.2. Increasing clinical trials for stem cell based-therapies
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost of cell-based research
      • 3.1.2.2. Ethical concerns related to embryonic stem cells
    • 3.1.3. Market Opportunities
      • 3.1.3.1. The emergence of iPSCs as an alternative to ESCs
      • 3.1.3.2. Increasing demand for cell & gene therapies

Chapter 4. Global Stem Cell Therapy Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Stem Cell Therapy Market, by Cell Source

  • 6.1. Market Snapshot
  • 6.2. Global Stem Cell Therapy Market by Cell Source, Performance - Potential Analysis
  • 6.3. Global Stem Cell Therapy Market Estimates & Forecasts by Cell Source 2019-2028 (USD Million)
  • 6.4. Stem Cell Therapy Market, Sub Segment Analysis
    • 6.4.1. Adipose Tissue-Derived Mscs (Mesenchymal Stem Cells),
    • 6.4.2. Bone Marrow-Derived Mscs,
    • 6.4.3. Placental/Umbilical Cord-Derived Mscs, And
    • 6.4.4. Other Cell Sources

Chapter 7. Global Stem Cell Therapy Market, by Type

  • 7.1. Market Snapshot
  • 7.2. Global Stem Cell Therapy Market by Type, Performance - Potential Analysis
  • 7.3. Global Stem Cell Therapy Market Estimates & Forecasts by Type 2019-2028 (USD Million)
  • 7.4. Stem Cell Therapy Market, Sub Segment Analysis
    • 7.4.1. Allogeneic Stem Cell Therapy
    • 7.4.2. Autologous Stem Cell Therapy

Chapter 8. Global Stem Cell Therapy Market, by Therapeutic Application

  • 8.1. Market Snapshot
  • 8.2. Global Stem Cell Therapy Market by Therapeutic Application, Performance - Potential Analysis
  • 8.3. Global Stem Cell Therapy Market Estimates & Forecasts by Therapeutic Application 2019-2028 (USD Million)
  • 8.4. Stem Cell Therapy Market, Sub Segment Analysis
    • 8.4.1. Musculoskeletal Disorders
    • 8.4.2. Wounds & Injuries,
    • 8.4.3. Cardiovascular Diseases
    • 8.4.4. Surgeries,
    • 8.4.5. Inflammatory & Autoimmune Diseases
    • 8.4.6. Neurological Disorders,
    • 8.4.7. Other

Chapter 9. Global Stem Cell Therapy Market, Regional Analysis

  • 9.1. Stem Cell Therapy Market, Regional Market Snapshot
  • 9.2. North America Stem Cell Therapy Market
    • 9.2.1. U.S. Stem Cell Therapy Market
      • 9.2.1.1. Cell Source estimates & forecasts, 2019-2028
      • 9.2.1.2. Type estimates & forecasts, 2019-2028
      • 9.2.1.3. Therapeutic Application estimates & forecasts, 2019-2028
    • 9.2.2. Canada Stem Cell Therapy Market
  • 9.3. Europe Stem Cell Therapy Market Snapshot
    • 9.3.1. U.K. Stem Cell Therapy Market
    • 9.3.2. Germany Stem Cell Therapy Market
    • 9.3.3. France Stem Cell Therapy Market
    • 9.3.4. Spain Stem Cell Therapy Market
    • 9.3.5. Italy Stem Cell Therapy Market
    • 9.3.6. Rest of Europe Stem Cell Therapy Market
  • 9.4. Asia-Pacific Stem Cell Therapy Market Snapshot
    • 9.4.1. China Stem Cell Therapy Market
    • 9.4.2. India Stem Cell Therapy Market
    • 9.4.3. Japan Stem Cell Therapy Market
    • 9.4.4. Australia Stem Cell Therapy Market
    • 9.4.5. South Korea Stem Cell Therapy Market
    • 9.4.6. Rest of Asia Pacific Stem Cell Therapy Market
  • 9.5. Latin America Stem Cell Therapy Market Snapshot
    • 9.5.1. Brazil Stem Cell Therapy Market
    • 9.5.2. Mexico Stem Cell Therapy Market
  • 9.6. Rest of The World Stem Cell Therapy Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. MEDIPOST
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Anterogen
    • 10.2.3. Regrow Biosciences
    • 10.2.4. Stempeutics Research
    • 10.2.5. CORESTEM
    • 10.2.6. PHARMICELL
    • 10.2.7. NuVasive
    • 10.2.8. RTI Surgical
    • 10.2.9. AlloSource
    • 10.2.10. JCR Pharmaceuticals

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption